Amicus Therapeutics/ US03152W1099 /
| 12/1/2023 9:59:58 PM | Chg. +0.18 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 11.22USD | +1.63% | 113,526 Turnover: 1.26 mill. |
-Bid Size: - | -Ask Size: - | 11.23 | 10.85 |
GlobeNewswire
3/16/2022
Amicus Therapeutics Announces Positive Long-Term Data from Phase 1/2 Study of AT-GAA in Pompe Diseas...
GlobeNewswire
3/10/2022
Amicus Therapeutics Announces Presentation and Posters at the 2022 MDA Clinical & Scientific Confere...
GlobeNewswire
3/1/2022
Amicus Therapeutics to Present at the Cowen 42nd Annual Health Care Conference
GlobeNewswire
2/24/2022
ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business...
GlobeNewswire
2/24/2022
Amicus Therapeutics Announces Full-Year 2021 Financial Results and Corporate Updates
GlobeNewswire
2/10/2022
Amicus Therapeutics to Announce Full-Year 2021 Financial Results on February 24, 2022
GlobeNewswire
2/7/2022
Amicus Therapeutics Announces Presentations and Posters at the 18th Annual WORLDSymposium™ 2022
GlobeNewswire
1/10/2022
Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue...
GlobeNewswire
1/5/2022
Amicus Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire
12/3/2021
European Medicines Agency Validates Amicus Therapeutics Marketing Authorization Applications for AT-...
GlobeNewswire
11/24/2021
Amicus Therapeutics to Present at the 4th Annual Evercore ISI HealthCONx Virtual Conference
GlobeNewswire
11/22/2021
Amicus Therapeutics Announces Presentations at the 14th International Congress of Inborn Errors of M...
GlobeNewswire
11/18/2021
The Lancet Neurology Publishes Pivotal Phase 3 PROPEL Study Results of AT-GAA in Late-Onset Pompe Di...
GlobeNewswire
11/11/2021
Amicus Therapeutics to Present at the Stifel 2021 Virtual Healthcare Conference
GlobeNewswire
11/9/2021
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of EJF, HTPA, ARYD, and AD...
GlobeNewswire
11/9/2021
Amicus Therapeutics Announces Third Quarter 2021 Financial Results and Corporate Updates
GlobeNewswire
11/3/2021
Amicus Therapeutics to Announce Third Quarter 2021 Financial Results on November 9, 2021
GlobeNewswire
10/6/2021
Moore Kuehn Encourages NOTV, ARYD, XLRN, and TGP Investors to Contact Law Firm
GlobeNewswire
10/1/2021
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of ARYA Sciences Acquisition Corp. IV...
GlobeNewswire
9/29/2021
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Ge...
GlobeNewswire
9/29/2021
U.S. FDA Accepts Filings for Amicus’ AT-GAA for the Treatment of Pompe Disease
GlobeNewswire
9/20/2021
Amicus Therapeutics Announces Presentations at the 26th International Annual Congress of the World M...
GlobeNewswire
9/3/2021
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2021
GlobeNewswire
8/5/2021
Amicus Therapeutics Announces Second Quarter 2021 Financial Results and Corporate Updates